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5 Health and Social Care Utilisation
Key Findings 
• The proportion of TILDA participants with a medical card or GP visit card increased 
overall between wave 1 and wave 2 (from 52% to 57%), but declined in those aged 70+ 
years�
• Between wave 1 and wave 2, private health insurance cover declined in those under 65 
years and increased in those aged over 65 years�
• In wave 2, 21�1% of participants aged 80+ years old had attended an Emergency 
Department (ED) at least once in the previous year (the corresponding figure for wave 
1 was 15�1%)� 
• Utilisation of community health and social care services by the older population 
remains low� 
• The uptake of prostate cancer screening services in men and breast cancer screening 
services women is high but the uptake of flu vaccination is low, particularly for those 
who do not have a medical or GP visit card� 
• Polypharmacy (i�e�, taking five or more medications) has increased from 21% at wave 1 
to 26% at wave 2�
• Participants who had died between wave 1 and wave 2 had higher levels of secondary 
care service utilisation (ED visits and hospital admissions) than survivors�
5.1    Introduction
Health service utilisation was reported in the first wave of TILDA on all those aged 50 years 
and over� This chapter reports on the health service utilisation two years later in those 
aged 52 years and older who took part in the second wave of the study (n=7,134)� This 
includes 7,010 participants who took part in both waves and 124 new participants� New 
participants in wave 2 include those previously deemed eligible to participate in wave 1 but 
who declined to do so at that time (n=122) and new partners/spouses of study participants 
(n=2)� Wave 2 participants are therefore slightly older on average than participants in wave 
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1 (mean age 65�5 years vs 63�8 yrs)�
In this chapter an expanded age categorisation is used to highlight the different patterns of 
service utilisation with increasing age, as well as differing public healthcare entitlements by 
age� Although differences in the cohort between the first and second waves of TILDA are 
discussed in detail in Chapter 7, differences across the age groups are highlighted here 
due to their relevance in the context of health service utilisation� The youngest age group 
(52-59 years) in wave 2 is systematically different to the youngest age group in wave 1 
which included participants aged 50-52 years. The oldest age group (≥80 years) are also 
older than the corresponding group in wave 1 (mean age 84�4 years vs 83�8 years)� This 
reflects differences in eligibility to participate between the waves� In wave 2 it became 
possible to interview participants or their proxy where the participant had been admitted to 
a nursing home or had become cognitively impaired�  
The chapter begins with a focus on health care entitlement status followed by utilisation 
of primary, secondary, community and home based services� The focus then turns to 
changes in prescribing patterns for older adults between the two waves� The final part of 
the chapter reports on health service utilisation in participants who died between wave 1 
and wave 2 of the TILDA study�
5.2    Medical card and private health insurance coverage 
There are two main categories of eligibility for public health services in Ireland, those with 
a medical card and those without� Those with a medical card are entitled to free General 
Practitioner (GP) care and public hospital services, free prescribed drugs and medicines 
subject to a €2.50 charge per item (from 1 December 2013), free dental, optical and aural 
services subject to certain limitations and a range of community care and personal social 
services� Eligibility for a medical card is means tested with different income thresholds 
applied at different ages� Those who do not meet the eligibility criteria for a medical card 
may qualify for a GP visit card, where the income thresholds are 50% higher than those 
for the medical card� The GP visit card entitles the holder to free GP visits; however, unlike 
the medical card the holder must pay out of pocket for all prescribed drugs and medicines� 
Under the Drugs Payment Scheme, all those without a medical card must pay the full cost 
of prescribed drugs and medicines up to a monthly deductible limit of €144 per family.
Universal entitlement to a medical card for all adults over 70 years was introduced in 2001� 
This universal entitlement was removed in 2009 and an income threshold for eligibility re-
introduced� The over 70s income threshold has subsequently been revised downwards 
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on an annual basis� During wave 2, a single person aged 70 years and older with a 
gross income of €700 per week or less or a couple over 70 years with a gross income of 
€1,400 per week or less qualified for a medical card under the scheme. Under The Health 
(Alteration of Criteria for Eligibility) Act 2013 this was revised downwards to €600 for a 
single person and €1,200 for a couple (1). The income thresholds for a medical card for 
persons over 70 years will be further reduced in 2014 to €500 per single person or €900 
per couple (2)
During wave 2 adults over 70 years with a gross weekly income of over €600 but not 
exceeding €700 for a single person (over €1,200 and not exceeding €1,400 for a couple) 
were entitled to a GP visit card (3)� Prescription charges were subsidised above a 
threshold of €132 per month under the Drugs Payment Scheme during the data collection 
period for wave 2, and this was increased to €144 per month from 1 January 2013. 
Those without a medical card or GP visit card must pay out of pocket for GP services� 
This group are entitled to free public hospital services subject to in-patient and out-patient 
hospital charges, subsidised prescription charges under the Drugs Payment Scheme and 
have no entitlement to personal social services� Supplementary private health insurance is 
purchased by many individuals in order to gain quicker access to hospital services� Some 
individuals with entitlement to a medical card or GP visit card purchase private health 
insurance in addition to these entitlements; this group is described as having ‘dual cover’ 
in this report� Those without private health insurance, a GP visit card or a medical card are 
described as having ‘no cover’ in this report�
During the period between wave 1 and wave 2 (wave 1 commenced in 2009, wave 2 
in 2012), due to the impact of the economic recession in Ireland, the number of Irish 
people eligible for medical cards increased and the number purchasing private health 
insurance decreased� In this period, the proportion of people with medical cards in the 
Irish population increased from 33�2% (1�4 million) at the beginning of 2010 to 37% (1�7 
million) at the beginning of 2012� The proportion of the population with GP visit cards also 
increased from 2�2% (98,300) to 3�1% (142,500) in the same time period (4, 5)�
For ease of comparison with wave 1,Table 5�1 shows the pattern of health care cover for 
all participants aged 50 years and older in wave 1 and Table 5�2 shows the pattern in all 
participants aged 52 years and older in wave 2� Due to the small number of participants 
with GP visit only cards this category is combined with the medical card category� The first 
four columns provide information on exclusive categories, i�e�, an individual can belong 
to one category only� The sixth column ‘All medical cards’ combines the two categories 
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of ‘Medical card only’ and ‘Dual cover’� The seventh column ‘All private health insurance’ 
combines the two categories ‘Private health insurance only’ and ‘Dual cover’�
Table 5.1: Health care entitlement status at wave 1 by age
Not covered
Private 
health 
insurance 
only
Medical card 
onlya Dual cover Total
All medical 
cardsa
All private
health 
insurance
Number 
in 
Sample
 % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
50-59 19 (17-20) 51 (49-53) 25 (23-27) 5 (4-6) 100 30 (28-33) 56 (54-59) 3271
60-64 10 (9-12) 50 (47-53) 31 (28-34) 9 (7-11) 100 40 (36-43) 59 (56-62) 1393
65-69 10 (8-12) 41 (37-44) 33 (30-36) 17 (14-19) 100 49 (46-53) 57 (54-62) 1196
70-79 1 (1-2) 8 (7-9) 53 (49-56) 38 (35-41) 100 91 (89-92) 46 (43-50) 1677
>=80 0 (0-1) 3 (2-4) 68 (64-72) 29 (25-33) 100 97 (95-98) 32 (28-36) 626
Total 11 (10-12) 37 (35-38) 36 (35-38) 16 (15-17) 100 52 (52-54) 53 (51-55) 8163
a Includes those with GP visit cards
Table 5.2: Health care entitlement status at wave 2 by age 
Not covered
Private 
health  
insurance 
only
Medical card 
onlya Dual cover Total
All medical 
cardsa
All private
health 
insurance
Number 
in 
Sample
 % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
52-59 18 (16-20) 48 (46-51) 27 (25-30) 6 (5-7) 100 34 (31-36) 54 (52-57) 2344
60-64 13 (11-15) 46 (43-50) 32 (29-35) 9 (7-11) 100 41 (38-45) 55 (52-59) 1333
65-69 7 (5-9) 42 (38-45) 35 (32-38) 17 (14-19) 100 52 (48-55) 58 (55-62) 1182
70-79 1 (0-1) 10 (9-12) 50 (46-53) 39 (36-42) 100 89 (87-90) 50 (46-53) 1579
>=80 1 (0-2) 4 (3-6) 65 (61-70) 29 (25-33) 100 95 (93-96) 34 (30-38) 686
Total 10 (9-10) 33 (32-35) 39 (37-41) 18 (17-19) 100 57 (56-59) 52 (50-53) 7124
The second wave of TILDA provides information on changing eligibility for free public 
health care in Ireland� While most of the changes between waves are not statistically 
significant, some interesting patterns emerge� Overall, the proportion of participants with 
medical /GP visit cards has increased from 52% at wave 1 (see Table 5�1) to 57% in wave 
2 (see Table 5�2)� This increase however is confined to those aged less than 70 years� The 
proportion with a medical/GP visit card decreased from 91% to 89% between waves in 
those aged 70-79 years and from 97% to 95% between waves in those aged 80 years and 
older� In total 92% of participants aged 70 years and older have a medical card or GP visit 
card in wave 2� 
A similar but opposite pattern can be seen in relation to private health insurance� The 
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overall proportion of the older population with private health insurance is slightly reduced 
from 53% at wave 1 to 52% at wave 2 (see Table 5�1 and Table 5�2)� A decrease in the 
proportion with private health insurance can be seen in those aged under 65 years and 
an increase in those aged 65 years and older, although none of these comparisons are 
statistically significant� The largest increase between the two waves can be seen in the 70-
79 year age group where 46% had private health insurance at wave 1 compared to 50% at 
wave 2�
The increase in private health insurance uptake at older ages is consistent with reports 
on the current age profile of the private health insurance market in Ireland� The numbers 
of people aged 60 years and over with private health insurance have increased annually 
between 2009 and 2011 compared to annual decreases in all age groups younger than 
60 years (6)�  As the income thresholds for entitlement to a medical card among the over 
70s have been reduced recently, this increase in uptake of private health insurance may 
suggest a need for reassurance by older people that they have sufficient cover in the event 
of need for health care� 
Recently published data from the Central Statistics Office revealed that 44% of Irish adults 
aged 65 years and older had private health insurance in 2011 (7)� Using this age as a cut-
off point, 46�5% of TILDA participants were found to have private health insurance in wave 
1 and 48% to have private health insurance in wave 2, representing a gradual increase in 
private health insurance uptake in this age group in the inter-wave period�
Almost a fifth of older adults have dual cover (private health insurance in addition to 
a medical/GP visit card)� Dual cover is uncommon in the 52-59 year age group and is 
relatively static between the two waves in those under 70 years� The proportion of the 
population with no cover has changed little across the waves�
5.3    Changes in medical card and private health insurance 
coverage
To examine transitions in health care entitlement categories between wave 1 and wave 2, 
in this sub-section we focus just on individuals that took part in both waves and provided 
details of their health care entitlement status at both waves (n=6,904)� Table 5�3 provides 
detailed information on the transitions from wave 1 to wave 2 between the five mutually 
exclusive health care entitlement categories defined in Tables 5�1 and 5�2�  
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Table 5.3: Changes in health care entitlement status between wave 1 and wave 2
Medical 
card 
only 
(wave 2)
GP card
 only
(wave 2)
Private 
health 
insurance 
only
(wave 2)
Dual private 
Health 
Insurance 
plus 
Medical/GP 
Card
(wave 2)
No Cover
 (wave 2) Total
Number 
in 
sample
(wave 1)
% % % % % %
Medical card only (wave 1) 96�0 0�3 0�3 2�4 1�0 100 2,001
GP card only (wave 1) 42�2 29�8 0�0 1�2 26�8 100 62
Private health insurance only 
(wave 1) 1�0 0�1 87�0 8�9 3�0 100 2,929
Dual private health 
insurance plus medical card/ 
GP card  (wave 1)
10�5 0�3 4�9 83�9 0�5 100 1,201
No cover (wave 1) 20�5 3�8 4�5 0�9 70�2 100 711
Number in sample (wave 2) 2210 60 2682 1334 618 100 6904
Of those who had a medical card only at wave 1, almost all continued to have a medical 
card only at wave 2 (96%) and a small proportion had purchased private health insurance 
in addition to their medical card cover by wave 2 (2�4%) (see Table 5�3)� While the number 
of participants with a GP visit card only at wave 1 was small, less than a third of these 
continued to have a GP visit card only at wave 2, 42�2% had obtained a medical card 
and 26�8% had no cover at wave 2� Almost 96% of those with private health insurance 
only at wave 1 retain their private health insurance alone or in conjunction with a medical 
card or GP visit card in wave 2 with a small proportion (3%) transitioning to no cover� This 
contrasts with those who held private health insurance in addition to either a medical card 
or a GP visit card at wave 1, a proportion of whom have relinquished their private health 
insurance in the inter-wave period and now rely more heavily on a medical card only 
(10�5%)� Of those with no cover at wave 1, 70�2% continued to have no cover at wave 2 
and 20�5% had become eligible for a medical card with only 3�8% becoming eligible for a 
GP visit card�
5.4    Utilisation of primary and secondary care services
Primary and secondary care service utilisation increased between wave 1 and wave 2� 
Utilisation of GP services remains high with 89�6% of participants in wave 2 indicating that 
they had visited their GP at least once in the previous year compared to 87�4% in wave 
1 (see Table 5�4)� Utilisation was highest in those with dual cover, followed by those with 
medical or GP visit cards� The lowest level of utilisation was found in those classified as 
having no cover� 
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Frequency of GP visiting was examined at wave two� One tenth of those aged 52 years 
and older did not visit a GP in the previous year and 63% visited between one and four 
times, 25% visited between 5 and 19 times and only 2% visited 20 or more times in the 
previous year (See Appendix Table 5�A1)� Frequency increased with age however a similar 
pattern can still be seen in those aged 80 years and older where 5% did not visit a GP in 
the previous year, 53 % visited 1-4 times, 39%  visited 5-19 times and 3% visited a GP 20 
times or more�
Table 5.4: Proportion utilising primary and secondary care services by age and health care 
entitlement status 
 GP visit (%) Outpatient visit (%)
Emergency 
Department 
(ED) visit (%)
Hospital 
Admission 
(%)
 wave 1
wave 
2
wave 
1
wave 
2
wave 
1
wave 
2
wave 
1
wave 
2
Age
50-59 (wave 1) 
52-59 (wave 2) 80�7 84�3 35�7 38�6 14�0 14�4 10�5 10�2
60-64 88�0 88�0 42�0 42�2 14�3 14�0 11�3 11�3
65-69 90�8 91�7 45�2 51�0 16�0 15�9 15�0 14�7
70-79 94�7 94�7 46�2 51�5 16�7 19�4 16�6 18�2
>=80 95�4 94�1 36�9 47�0 15�1 21�1 15�6 24�8
Total 87�4 89�6 40�2 45�0 14�9 16�4 12�9 14�6
Health entitlement status
Not covered 74�3 75�1 31�3 31�2 13�2 11�6 5�9 6�8
Private health insurance 
only 82�3 86�0 36�9 39�3 11�8 12�5 10�0 9�8
Medical/GP visit card only 93�0 92�8 43�3 49�4 18�0 19�5 15�9 16�9
Dual cover 95�3 97�0 46�8 53�1 16�2 19�7 17�1 22�6
Total 87�4 89�6 40�2 45�0 14�9 16�5 12�9 14�6
The proportion of older adults attending hospital as on outpatient in the year prior to the 
survey has increased by almost 5 percentage points between wave 1 and wave 2 (see 
Table 5�4)� Utilisation increased the most between the two waves in those with dual cover 
and those with medical or GP visit cards only� The increase is especially apparent in those 
over 80 years where the proportion attending hospital as an outpatient in the previous 
year increased by over 10 percentage points between the two waves (36�9% to 47%)� The 
increase in outpatient activity found at wave 2 may reflect a changing waiting pattern for 
outpatient services which came about as a result of the Department of Health’s Special 
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Delivery Unit (SDU)� The SDU was set up in 2011 by the Minister for Health and tasked 
with implementing performance improvement in Irish hospitals� One of the targets set was 
to reduce outpatient waiting lists to no more than 12 months in the 2011 period and to 
reduce this further to 9 months in 2012� As a result there was an increase in activity in the 
outpatient sector aimed at addressing those who had been waiting longest�
Utilisation of emergency department (ED) services in the year prior to the survey increased 
slightly between waves 1 and 2 of TILDA (see Table 5�4)� Utilisation was highest and 
increased the most in those with dual cover� The largest increase in ED utilisation can be 
seen in those aged 80 years and older. Just over 15% of this age group reported an ED 
visit in the first wave compared to 21�1% in wave 2 (see Table 5�4)� Some of this change 
is likely due to the older age profile of those over 80 years in wave 2� Given the high levels 
of multi-morbidity in older adults, this finding highlights the need for service providers to 
actively consider the needs of this older age group in EDs and to provide renewed focus 
on primary care and community-based interventions which aim to reduce dependency on 
the ED�
Admission to hospital in the previous year has also increased in the older age group 
80+  years) in wave 2; 24�8% of those aged 80 and over had experienced at least one 
admission in the previous year compared to 15�6% in wave 1� 
5.5    Primary prevention and Screening
5.5.1    Prostate cancer screening 
Excluding non-melanoma skin cancer, prostate cancer is the most frequently diagnosed 
cancer in men in Ireland (8)� There is no population-based screening programme for 
prostate cancer in Ireland due to insufficient evidence to recommend the introduction of a 
prostate cancer screening programme (9)� Despite this, there is widespread screening at a 
local level� The majority of men in TILDA have had a prostate cancer test (an examination 
of their prostate to screen for cancer or a Prostate Specific Antigen (PSA) test)� In wave 1 
72�8% of men aged 50 years and older indicated that they had previously had a prostate 
cancer test� At wave 2 this proportion rose to 81�8% in those aged 52 years and older (see 
Table 5�5)�
As this test is not population-based, health care entitlement status provides an insight into 
the pattern of uptake� A higher proportion of those with private health insurance (either in 
combination with a medical/GP visit card or private health insurance only) had prostate 
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cancer screening carried out compared to those with a medical or GP visit card only or 
those with no cover (in both waves)� Overall the proportion of men being screened for 
prostate cancer is high suggesting perceived importance of this test and a willingness to 
pay for this service even in the group of men classified as having no cover�
Men who indicated that they had a PSA test carried out at wave 1 were asked in wave 2 if 
they had a repeat test conducted since the time of their first interview�  Almost 79% had a 
repeat test carried out between the two waves� Men who had not been tested at the time 
of their first interview were asked if they had been tested between the two waves� In this 
group 44% were found to have been tested for the first time in the inter-wave period� 
Table 5.5: Proportion utilising primary and secondary prevention services by age and 
health care entitlement status
 
Prostate 
cancer test
(Men only) 
(%)
Cholesterol 
test (%)
Flu 
vaccination 
(%)
Mammogram
(Women only) 
(%)
Check for 
breast lumps
(Women only) 
(%)
 wave 1
wave 
2
wave 
1
wave 
2
wave 
1
wave 
2
wave 
1
wave 
2
wave 
1
wave 
2
Age
50-59 (wave 1) 52-59 (wave 
2) 65�2 74�8 83�2 91�4 28�5 32�8 83�7 94�6 72�8 69�8
60-64 77�9 81�7 89�7 94�5 41�8 44�9 91�9 96�6 73�5 71�5
65-69 82�0 86�7 92�1 95�6 60�4 62�7 83�6 91�7 67�9 64�1
70-79 78�7 89�1 91�0 97�0 79�1 81�7 55�2 66�4 59�4 55�5
>=80 72�2 83�1 86�3 92�7 83�9 88�4 26�1 31�4 48�3 36�5
Total 72�8 81�8 87�3 94�0 49�9 57�0 73�1 79�3 66�9 61�3
Health entitlement status
Not covered 58�6 69�5 75�8 86�0 25�5 30�4 79�4 89�7 71�8 66�4
Private health insurance 
only 79�3 87�5 89�5 95�3 34�7 40�9 89�4 95�8 71�7 67�8
Medical/GP visit card only 64�7 75�3 86�1 93�1 63�2 68�8 59�0 66�4 63�6 57�5
Dual cover 85�2 92�0 92�9 97�7 71�6 75�2 70�2 76�1 62�7 57�1
Total 72�8 81�8 87�3 94�0 50�0 57�0 73�1 79�3 66�9 61�3
 
5.5.2    Cholesterol testing
Cholesterol testing is widespread in this population of older adults� In wave 1 87�3 % of 
those aged 50 years and older had ever had a blood test for cholesterol, and this rose to 
94% at wave 2 in those aged 52 years and older (see Table 5�5)� The proportions of men 
and women tested were similar�
5 Health and Social Care Utilisation
133
Cholesterol testing was highest in those with dual cover and lowest in those with no cover� 
Participants who indicated that they had previously had a blood test for cholesterol carried 
out at wave 1 were asked in their second interview if they had a repeat test conducted 
since the time of their first interview� Of these 85% had a repeat cholesterol test carried 
out between the two waves� In those that had never had a cholesterol test at wave 1, 
61% were tested for the first time between their two interviews� More than two thirds of 
these participants had their cholesterol tested as part of the health assessment in the first 
wave of TILDA suggesting that the study has impacted on the higher uptake of cholesterol 
testing at wave 2�
5.5.3    Flu vaccination 
Annual vaccination for influenza with the most recent virus strains was previously 
recommended for all adults over 65 years of age but from 2013 it is recommended for 
all adults over 50 years of age (10)� The vaccine is provided free of charge but for those 
without a medical or GP visit card a consultation fee for administering the vaccine must be 
paid. A GP consultation costs from €45-€60 or higher compared to a community pharmacy 
consultation which costs from €15-€27.50 (11-13). Evidence from TILDA suggests that the 
uptake of the flu vaccine is low overall� In the first wave of TILDA 49�9% of those over 50 
years had ever received a flu vaccination; this increased to 57% of those aged 52 years 
and older in wave 2 (see Table 5�5)�
A higher proportion of those with dual cover or with medical/GP cards received flu 
vaccination compared to those with private health insurance only or no cover� Although the 
vaccine is free to all, less than a third of those with no cover had received a flu vaccination 
in both waves� This suggests that the GP or pharmacy consultation fees for those without a 
medical or GP visit card may constitute a barrier to flu vaccination uptake� 
There was a high level of repeat flu vaccination (81%) in those that had been vaccinated 
at wave 1� Repeat vaccination was especially high in those aged 80 years and older 
which reached almost 89%� This suggests that the perceived importance of this vaccine 
and the acceptability of it are high in this older age group� In those that had never been 
vaccinated against flu in wave 1, only 17% had received a flu vaccination by the time of 
their interview for wave 2� These figures are low considering the widespread campaigns for 
flu vaccination which are run on an annual basis� 
5.4.4    Breast Cancer Screening
In Ireland the National Breast Screening Programme (BreastCheck) offers women aged 
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50-64 years a free mammogram every two years� The proportion of women over 50 
years who had ever had a mammogram was 73�1% in wave 1� This increased to 79�3% 
of those over 52 years at wave 2 (see Table 5�5)� The success of this national screening 
programme is reflected in the fact that breast screening by women in the target age groups 
is 95% at wave 2� 
Of those that had a mammogram at wave 1 65% had undergone a repeat test in the inter-
wave period� Repeat testing was highest in the younger age groups targeted for screening�
In wave 1 66�9% of women over 50 years indicated that they checked their breasts 
regularly for lumps; and this dropped to 61�3% of women over 52 years at wave 2 (see 
Table 5�5)� A very clear age gradient can be seen in relation to breast self-examination with 
a lower proportion of older women conducting breast self-examination�
5.6    Utilisation of community-based state care services
Participants were asked if they had utilised any of the community-based state care 
services in Table 5�6 in the preceding twelve months� They were asked to exclude any 
services for which they had paid anything other than a token or nominal amount� Unlike 
utilisation of GP services and acute hospital services which increased between the 
two waves, three of the community-based services outlined below show decreases in 
utilisation� 
Table 5.6: Proportion utilising community-based state care services
 wave 1(≥50yrs )
wave 2
(≥52yrs )
Change
 Between
 waves
 % (95% CI) % (95% CI)
Public Health or Community Nurse 6�6 (5�9-7�3) 6�5 (5�8-7�3) -0�1
Occupational therapy 1�5 (1�2-1�8) 1�7 (1�4-2�1) 0�2
Chiropody/podiatry services 4�5 (4�0-5�2) 5�2 (4�6-5�9) 0�7
Physiotherapy services 5�2 (4�7-5�7) 5�8 (5�2-6�5) 0�6
Psychological /counselling services 0�8 (0�7-1�1) 1�0 (0�8-1�3) 0�2
Day centre 1�2 (1�0-1�5) 1�5 (1�2-1�8) 0�3
Optician 12�3 (11�3-13�3) 14�8 (13�8-15�9) 2�5
Dental services 10�7 (9�9-11�6) 9�2 (8�4-10�1) -1�5
Hearing services 1�8 (1�5-2�1) 3�2 (2�8-3�7) 1�4
Dietician services 1�5 (1�2-1�8) 1�4 (1�2-1�8) -0�1
Respite services 0�5 (0�3-0�7) 0�6 (0�4-0�9) 0�1
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Utilisation rates range from 14�8% for optician services to 0�6% for respite services (see 
Table 5�6)� There was little change in utilisation of community-based services between the 
two waves� The largest increase can be seen in the optician services, where the proportion 
of the population utilising the service increased from 12�3% in wave 1 to 14�8% in wave 
2� Utilisation of dental services, public health nurse or community nurse services and 
dietician services recorded small decreases between wave 1 and wave 2� 
Almost 70% of participants in wave 2 use none of these community services� Utilisation is 
highest in those over 80 years where 59% of participants use at least one of the services 
identified�
The vast majority of older people utilising community-based state care services are 
medical card holders (see Appendix Table 5�A2)� An interesting pattern is seen in these 
data in relation to those with dual cover� The data suggest that those with medical cards as 
well as private health insurance may also gain additional access to community-based state 
services where co-payments are a feature of the service� In the case of chiropody/podiatry 
services, 66% of users were medical card holders and a further 29% had dual cover 
(private health insurance in addition to a medical card or GP visit card) (see Appendix 
Table 5�A2)� Although state chiropody/podiatry services are available to medical card 
holders, individuals are required to pay an additional co-payment of €15-40 per visit when 
attending private practitioners to avail of the service (14)� These results suggest that the 
presence of a co-payment in some services may negatively impact access to services� As 
health care entitlement status is also strongly related to age and need for health care, this 
issue requires further investigation�
5.7    Disability prevalence and utilisation of home care services
5.7.1    Disability prevalence
Disability prevalence will now be discussed in relation to the wave 2 cohort aged 52 
years and older� Disability prevalence has been discussed previously in a subgroup in 
Chapter 4 and will be discussed further in Chapter 6 in a subgroup who completed the 
self-completion questionnaire� The results in this section are not comparable with either of 
these chapters due to the different samples used in the analyses�
The prevalence of disability by age and sex is described in Table 5�7� Disability is defined 
here as difficulty in carrying out activities of daily living (ADL) and instrumental activities of 
daily living (IADL)� ADL are the basic tasks of everyday life that pertain to personal care, 
The Irish Longitudinal Study on Ageing
136
and six items are included in this scale: difficulty with dressing; walking across a room; 
bathing or showering; eating, getting in and out of bed; and using the toilet� IADL assesses 
difficulty in relation to carrying out household activity including: preparing a hot meal; doing 
household chores; shopping for groceries; making telephone calls; taking medications; and 
managing money� In the case of both ADL and IADL difficulties, participants were asked to 
exclude any activities that they expected would last less than three months�
The data revealed a slight increase in the proportion of older people in Ireland who are 
not disabled (87% in wave 1 to 88% in wave 2) (see Table 5�7)� This positive trend can be 
seen in all age groups under 80 years, however the trend is in the opposite direction in 
those aged 80 years and older� Systematic differences in the older age category described 
at the beginning of this chapter may account for some of this difference�  
The pattern of disability in wave 2 is broadly similar to wave 1 with more women than men 
experiencing disability� There is a strong age gradient in disability, only 5% of the youngest 
age group in wave 2 experience disability compared to 39% of those aged 80 years and 
older (Table 5�7)� Although the number of participants aged 90 years and older is small, 
examination of the data using an expanded age category reveal that 65% experience 
some form of ADL or IADL disability (see Appendix Table 5�A3)� These findings have 
particular policy relevance in relation to independent living for older adults and the support 
required to remain living at home in advanced older age�
Table 5.7: Prevalence of ADL and IADL disability by age and sex
 
Not disabled
% (95% CI)
IADL disability only % 
(95% CI)
ADL disability only % 
(95% CI)
IADL and ADL disability 
% (95% CI)
 wave 1 wave 2 wave 1 wave 2 wave 1 wave 2 wave 1 wave 2
Age
50-59 (wave 1) 
52-59 (wave 2) 93 (91-93) 95 (94-96) 3 (2-3) 2 (2-3) 3 (2-4) 1 (1-2) 2 (2-3) 2 (1-2)
60-64 90 (88-92) 94 (92-95) 2 (2-3) 2 (2-3) 5 (4-6) 2 (1-3) 2 (2-3) 2 (1-3)
65-69 89 (87-91) 90 (88-92) 3 (2-4) 3 (2-4) 6 (5-8) 4 (3-5) 3 (2-4) 3 (2-4)
70-79 82 (79-84) 85 (83-87) 5 (4-7) 7 (5-8) 7 (6-7) 3 (2-4) 6 (5-8) 6 (5-7)
>=80 66 (61-70) 61 (57-65) 12 (10-16) 16 (13-19) 7 (5-9) 4 (3-6) 15 (12-19) 19 (15-22)
Total 87 (86-88) 88 (87-88) 4 (3-4) 5 (4-6) 5 (4-5) 3 (2-3) 4 (4-5) 5 (4-6)
Sex
Male 89 (88-90) 90 (89-91) 3 (2-3) 4 (3-5) 6 (5-7) 3 (2-3) 3 (2-4) 3 (3-4)
Female 86 (84-87) 85 (84-86) 5 (4-6) 6 (5-7) 4 (3-5) 2 (2-3) 5 (5-6) 6 (5-7)
Total 87 (86-88) 88 (87-89) 4 (3-4) 5 (4-6) 5 (4-5) 3 (2-3) 4 (4-5) 4 (4-6)
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 A decrease of two percentage points can be seen between the two waves in ADL 
disability� In wave 1, participants were asked about difficulty with dressing which included 
difficulty with putting on socks and shoes� At wave 2 the question was asked about 
difficulty with dressing only� This change in wording is likely to have impacted on the 
endorsement of this item in the survey� Future waves will capture both items�
5.7.2    Utilisation of home help, personal care and meals services 
There was a slight change in the proportions utilising home-based social care services 
between the two waves� Home help utilisation increased from 3�5% at wave 1 to 4�4% 
at wave 2� In the context of an overall reduction in home help service hours from 11�9 
million at the end of 2009 to 11 million hours at the end of 2011, this result appears counter 
intuitive (15, 16)� Utilisation is concentrated in those over 80 years with one fifth of this 
group using home help services at wave 2 (see Table 5�8)� It is likely that the increase 
found is related to the older age profile of community-living participants in this cohort as 
discussed earlier in this chapter� 
Table 5.8: Proportion utilising home help, personal care and meals services by age, sex, 
health care entitlement status and disability status
 Home help (%) Personal care attendant (%) Meals services(%)
 wave 1 wave 2 wave 1 wave 2 wave 1 wave 2
Age
50-59 (wave 1) 52-59 (wave 2) 0�5 0�5 0�1 0�3 0�1 0�1
60-64 1�0 1�2 0�1 0�5 0�3 0�2
65-69 1�6 2�0 0�2 0�9 0�3 0�5
70-79 6�2 5�4 0�9 1�7 2�4 1�8
>=80 19�2 20�5 3�4 5�2 3�3 3�6
Total 3�5 4�4 0�6 1�3 0�9 1�0
Entitlement status
Not covered 0�1 0�6 0�0 0�0 0�0 0�0
Private health insurance only 0�4 0�3 0�1 0�1 0�1 0�1
Medical card only 6�7 8�3 1�2 2�5 2�0 2�0
Dual cover 5�7 5�1 0�7 1�7 1�0 0�7
Total 3�5 4�3 0�6 1�3 0�9 0�9
Disability status
Not disabled 1�8 1�9 0�2 0�2 0�5 0�4
IADL disability only 16�6 20�5 1�1 2�4 4�6 3�3
ADL disability only 5�2 8�2 0�8 3�2 1�4 1�1
IADL and ADL disability 24�0 30�1 7�9 19�8 5�3 7�9
Total 3�5 4�4 0�6 1�3 0�9 1�0
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In wave 1 IADL difficulty was found to be a strong driver of home help services for older 
adults (17)� While this continues to be the case in wave 2 it is important to point out 
that 1�9% of the non-disabled population (i�e�, those that self-report no ADL or IADL 
difficulty) are availing of home help services (see Table 5�8)� While this constitutes a small 
percentage the numbers are large relative to the total number utilising home help services�
Intensity of home help service utilisation was examined in those that utilised the service in 
the previous month� The majority (70%) received one hour of help on the days when they 
received home help� The total number of hours of service utilised in the previous month 
was between one and eight hours for 37% of home help service users and was greater 
than 32 hours for just 12% of service users� These results paint a picture of a home help 
service which provides a low level of care intensity� 
The proportion of the population using personal care services increased from 0�6% to 
1�3% between the two waves� This result is likely to reflect the increase in the provision 
of home care packages by the Health Service Executive (HSE)� These packages of care 
provide an enhanced level of support above the normal levels of home help and personal 
care available from mainstream community services� The number of older people in receipt 
of home care packages increased from 12,000 at the end of 2009 to 15,000 at the end of 
2011(15, 16)� The TILDA results reveal that utilisation of personal care services increased 
from 7�9% of those with a combined ADL and IADL disability at wave 1 to 19�8% at wave 
2� Although the proportion utilising the service overall is low, the increased utilisation of 
personal care services by those with higher levels of ADL/IADL disability is consistent with 
Government policy to provide an enhanced level of home support for older people� Home 
care packages are allocated on the basis of assessed need and there is no requirement to 
have a medical card (18)� Wave two data indicate that personal care utilisation increased 
between wave 1 and wave 2 in those with a medical card only (from 1�2% to 2�5%) and in 
those with dual insurance cover (0�7% to 1�7%)� There was no change in the proportions of 
older people reporting use of meals services between the two waves�
5.8    Medication use and polypharmacy 
Medication use in the older population is particularly important given the high levels 
of multi-morbidity and increased predisposition to side effects which comes with age� 
Polypharmacy, defined as the regular use of 5 or more medicines, is common among 
the older population and is associated with lower health and increased morbidity� 
Polypharmacy is often necessary for management of difficult illnesses or conditions, which 
require complex care� However, inappropriate or over-prescribing is also a factor, exposing 
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patients to risks of drug interactions and adverse drug reactions�
Changes in medication use in participants who took part in wave 1 and wave 2 is 
examined in Table 5�9� Total prevalence of medication use in wave 1 is displayed in the 
first column and total prevalence at wave 2 in the last row� As expected medication use has 
increased as the cohort is two years older� At wave 1 21% of participants reported using 5 
or more medications regularly, and this increased to 26% in wave 2� Correspondingly, the 
number of participants reporting no regular medication use dropped from 28% in wave 1 to 
24% in wave 2� 
Changing patterns of medication use is also examined in Table 5�9� For those who have 
increased their medication use in wave 2 the majority have just moved up one group� 
For example of those who were not regularly taking medications at wave 1, the majority 
69% were still not taking any regular medications at wave 2 while 24% had progressed 
to the 1-2 medications group� The same holds true for the other groups� The numbers 
who have significantly increased their medication use is relatively low; 2% of those 
using no medication and 7% of those using 1 – 2 medications in wave 1 are now in the 
polypharmacy category (5+ medications)� While the prevalence of polypharmacy has 
increased overall, 15% of those who were taking 5 or more medications regularly in wave 
1 have reduced their medication use in wave 2� 
Table 5.9: Changes in medication use between wave 1 and wave 2
Total 
(wave 1)% 
0 
Medications 
(wave 2)
1-2 
Medications 
(wave 2)
3-4 
Medications 
(wave 2)
5+ 
Medications 
(wave 2)
Total
Number 
in sample
% % % %
0 Medications (wave 1) 28 69 24 4 2 100 2339
1-2 Medications (wave 1) 29 8 62 23 7 100 2215
3-4 Medications (wave 1) 21 2 14 52 33 100 1377
5+ Meds (wave 1) 21 1 2 12 85 100 1216
Total (wave 2) % 100 24 29 21 26 100 7147
Figure 5�1 breaks down the wave 2 numbers by 5-year age groups, revealing a broadly 
linear increase with age in the mean number of medications used until age 80, after which 
it levels off at age 85+� 
Further information on medication use in wave 2 by both age and sex is available in 
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Appendix Figure 5�B1� Men report less medication use than women, particularly in the age 
range 52–64 years� This trend decreases over age, with both sexes reporting nearly the 
same medication use after age 75� Larger proportions of the older age groups use more 
medications, with nearly 50% of those aged 75 years and over reporting polypharmacy� 
Reporting higher medication use is also strongly associated with lower education, lower 
self-rated health and decreased physical activity (see Appendix Tables 5�A4-5�A6)�  
Figure 5.1: Mean number of medications (excluding food supplements) used in wave 2 by 
age
0.0
1.0
2.0
3.0
4.0
5.0
52-54 55-59 60-64 65-69 70-74 75-79 80 85+
Note. N = 7282; M issing obs = 0; Error bars correspond to 95% confidence interva ls
The five most common medications has remained similar across both waves with a 
slight alteration in order (see Table 5�10)� Medication classes (ATC level 2) and food 
supplements have remained the same� Food supplements were defined according to the 
European Directive 2002/46/EC as any substance with a nutritional effect which is taken to 
supplement the normal diet� The five most frequently reported food supplements account 
for a similar proportion of the total supplements used (79% in wave 1 and 78% in wave 2)� 
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Table 5.10: Top five most commonly used medications, medication classes and food 
supplements 
Individual medications
(International Non-
proprietary name)
Medication classes
(ATC Level 2) Food supplements
wave 1 wave 2 wave 1 wave 2 wave 1 wave 2
1 Aspirin Aspirin Lipid modifying agents (C10)
Lipid modifying 
agents (C10)
Calcium 
carbonate, 
combinations
Calcium 
carbonate, 
combinations
2 Atorvastatin Atorvastatin
Agents acting 
on the rennin-
angiotensin 
system (C09)
Agents acting 
on the rennin-
angiotensin 
system (C09)
Omega-3-
triglycerides
Omega-3-
triglycerides
3 Levothyroxine Rosuvastatin Anti-thrombotic drugs (B01)
Anti-thrombotic 
drugs (B01) Glucosamine Glucosamine
4 Bisoprolol Bisoprolol
Drugs for acid 
related disorders 
(A02)
Drugs for acid 
related disorders 
(A02)
Vitamin B, 
combinations
Vitamin B, 
combinations
5 Rosuvastatin Levothyroxine Beta blocking agents (C07)
Beta blocking 
agents (C07) Multivitamins Multivitamins
5.8.2    Use of generics: the case of Atorvastatin
Statins are one of the most commonly prescribed medicines in the older population and 
generate the largest expenditure (19)� They are used to help lower low density lipoprotein 
cholesterol (LDL-C) in the prevention and treatment of cardiovascular disease� When 
looking at generic drug use we can use four broad categories of drug type: pure generic 
which is sold using the active pharmaceutical name (e�g� Atorvastatin); branded generic 
which is sold using a marketing name (e�g� Torvacol); proprietary brand with a generic 
equivalent (e�g� Lipitor); proprietary brand without a generic equivalent (i�e� a drug still 
under patent protection)� Generic medicines are usually cheaper than the proprietary 
brand, and thus they provide the same level of medication intervention at a lower cost� Of 
all the medications used by the older population only 20% were generics at wave 1 with a 
slight increase to 22% at wave 2� There is a more dramatic increase in generic use for the 
statin group of medications, with the proportion of generics increasing from 8�5% at wave 
1 to 23�5% at wave 2 due to the expiry of patents� Between the first and second waves 
of TILDA data collection the most prevalent statin, Atorvastatin, came off patent which 
allowed the entry of generic competitor medicines by wave 2� This provides an interesting 
insight into the initial effect of a drug patent expiry on medication use� 
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Table 5.11: Generic share of Atorvastatin at wave 2 by wave 1 use and medical card status
wave 2 previous Lipitor users wave 2 
Market 
share
New users
%
n=424
wave 2
Market 
share
All
users
%
n=1,357
Market 
share 
% 
n=967
Medical 
cards usersa 
% 
n=614
Non-medical 
card usersb 
%
n=351
Pure generic 11�0 14�5 5�1 13�9 11�9
Branded generic 0�9 1�3 0 1�9 1�2
Proprietary brand with 
a generic equivalent 88�1 84�2 94�9 84�2 86�9
Proprietary brand 
without a generic 
equivalentc
0 0 0 0 0
Total 100 100 100 100 100
a Four individuals are missing medical card status.
b Includes GP card holders.
c This category does not apply once a drug comes off patent, but was 100% for Atorvastatin in wave 1.
Atorvastatin accounts for 57% of all statin use in wave 1 and 56% in wave 2, in addition to 
being the second most used medication in both waves� Table 5�11 shows the effect of the 
patent expiry on Lipitor (the branded version of Atorvastatin, which did not have a generic 
equivalent in wave 1) which occurred during the inter-wave period� While some individuals 
who were using Lipitor in wave 1 have moved to generic versions (11%) the majority of 
patients have remained on the proprietary brand (88�1%)� This is most evident in those 
who do not have a medical card, with 94�9% remaining on the proprietary brand� This 
contrasts sharply with previous Lipitor users in England where only 31% of patients have 
initially remained on the proprietary brand (20)� Evidence from TILDA wave 2 suggests 
that private patients (i�e�, those without a medical card) in this case are more resistant to 
generic substitution, with only 5% switching� In general there is a higher use of generics in 
wave 2 among those who were not previously using Lipitor� 
Two recent measures should have a considerable impact on future prescribing patterns 
in Ireland� Firstly, the HSE has commenced a medicines management programme to 
encourage cost effective prescribing� As part of this programme, Simvastatin has been 
designated the preferred statin for initial treatment� Secondly, the Health (Pricing and 
Supply of Medical Goods) Act 2013 has introduced the legislation to implement generic 
substitution at the pharmacy level and a system of drug group reference pricing for 
reimbursement (21)� Generic substitution for Atorvastatin was introduced in August 2013 
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and drug group reference pricing was introduced in November 2013� The effects of both of 
these measures will be visible in future waves of TILDA�
5.9    Health service utilisation at the end of life
In this section the health service use of those who died since wave 1 of the TILDA survey 
is described� Patterns of service use among the deceased are compared to participants 
who were still alive at wave 2� At the end of wave 2 data collection, there were a total of 
205 deaths among participants� Data from ‘end of life’ interviews were available from 155 
individuals acting as a proxy participant for deceased participants� Most proxy participants 
were relatives of the deceased participant including the son or daughter (including in-
law) (43�8%), or the spouse or partner of the deceased (30�9%)� Other proxy participants 
included siblings (7�7%), other relatives (8�4%) and other non-relatives (8�4%)� The end 
of life interview included questions on use of health services in the 12 months before the 
TILDA participant died, his/her physical and behavioural health, cognitive function and 
financial circumstances�
Of those who died, 55% were men and the average age of the deceased was 75�5 years 
(median 77 years)� Most of those who died were married (40�6%) or widowed (40�0%) and 
19�3% were single separated or divorced at the time of death�  Almost half of the deceased 
died in hospital (48�4%), approximately one quarter died at home (24�5%) and 9�7% died in 
a nursing home or residential care setting� Approximately 13% died in a hospice and 4�5% 
died at other locations�
The most common causes of death reported by proxy participants were cancer (37�5%), 
followed by cardiovascular-related causes (28�9%), other causes such as digestive 
disorders, infectious disease, accidents (21�1%) and respiratory causes (12�5%)� There 
were no differences between men and women in terms of the main causes of death� 
There was some evidence that more people died from respiratory diseases in the older 
age groups (3�4% of those aged 50-64 compared to 13�3% of those aged 65-74 and 
15.2% of those aged ≥75 years) but the association between age and cause of death 
was not statistically significant� In terms of physical health prior to death, 41�3% of proxy 
participants described the deceased as mostly active and disability free but declining 
during the last few months before death� In total, 25�8% of proxy participants reported that 
the deceased had been ill for one year or more before he/she died�
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Table 5.12: Proportion of deceased and survivors utilising primary and secondary care 
services at wave 2
Deceased wave 2 Survivors
% (95% CI) % (95% CI)
GP visit 87�1 (81�8-92�4) 89�6 (88�7-90�2)
Outpatient 42�6 (34�7-50�5) 45�0 (43�4-46�2)
Emergency Department 44�5 (36�6-52�4) 16�4 (15�3-17�2)
Hospital admission 59�4 (51�5-67�2) 14�6 (13�5-15�2)
Table 5�12 shows the pattern of utilisation of different types of health services in the 12 
months before death� Health service use in the deceased group is compared to those 
survivors who participated in wave 2� The percentages are for those who used the services 
at least once in the previous year� The majority of those who died had attended the GP in 
the 12 months before death according to the proxy respondent� In contrast, less than half 
had attended an out-patient clinic or the ED� A higher proportion of people who died had 
attended an ED or had a hospital admission in the 12 months preceding death compared 
to participants in wave 2� 
The end-of-life interviews also allow for an examination of the proportions of deceased 
individuals who received three types of state-provided home care services in the last 12 
months of life: home help, meals services and the services provided by personal care 
attendants� Approximately 25% of deceased individuals received home help in the year 
preceding death, 11% had the help of a state-provided personal care attendant and 7�7% 
received meals services (Table 5�13)� The majority of proxy respondents reported that the 
deceased received none of the state services outlined above (67�1%)� A higher proportion 
of those who died were utilising state-provided home services in the preceding 12 months, 
compared to survivors at wave 2�
Table 5.13: Proportion of deceased and survivors utilising home help, personal care and 
meals services at wave 2
Deceased wave 2 Survivors
% (95% CI) % (95% CI)
Home help 25�2 (18�3-32�1) 4�4 (3�5-4�6)
Personal care attendant 11�0 (6�0-15�9) 1�3 (0�9-1�5)
Meals services 7�7 (3�5-12�0) 1�0 (0�7-1�2)
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5.10    Conclusion
Maintaining and improving population health and well-being is a key goal of Irish health 
policy� Current Government policy aims to manage and prevent illness at the earliest 
stage possible (22)� It is encouraging to find that the uptake of primary prevention and 
screening programmes has increased in the older population across the first two waves 
of TILDA, although there is some evidence that those without a medical card or GP visit 
card may face access barriers with regard to flu vaccination� The data identify a reduction 
in the proportion of older people over 70 years with full access to primary and secondary 
care services at a time in their life when their need for health and social care is increasing, 
especially in the period at the end of life� Current health service reforms are aimed at 
reducing the reliance on secondary care services and providing integrated primary and 
community-based care where possible� The findings in this chapter reveal a continued 
and increasing utilisation of primary GP services and secondary care services but minimal 
change in the community health and social care sector�
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Appendix 5B: Figures on Health and Social Care Utilisation
Figure 5.B1: Medication use in wave 2 by age and sex
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Note. N = 7127; M issing obs = 7; Error bars correspond to 95% confidence interva ls
